Search

Your search keyword '"García-Carro, Clara"' showing total 164 results

Search Constraints

Start Over You searched for: Author "García-Carro, Clara" Remove constraint Author: "García-Carro, Clara" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
164 results on '"García-Carro, Clara"'

Search Results

1. Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy

4. Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

7. WCN24-2513 TRANSIENT ACUTE KIDNEY INJURY AFTER CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES

8. Transient acute kidney injury after chimeric antigen receptor T-cell therapy in patients with hematological malignancies

9. The need for renal biopsy in oncology patients on check-point inhibitors check-point inhibitors: New triggers for extracapillary glomerulonephritis extracapillary glomerulonephritis

10. Results from the IRoc-GN international registry of patients with COVID-19 and glomerular disease suggest close monitoring

13. Genetic testing in focal segmental glomerulosclerosis: in whom and when?

14. Diagnosis and treatment of lupus nephritis: a summary of the Consensus Document of the Spanish Group for the Study of Glomerular Diseases (GLOSEN)

18. Efectos renales adversos por inhibidores del check-point (ICP) en pacientes con cáncer. Recomendaciones del grupo de Onconefrología de la Sociedad Española de Nefrología (SEN)

19. Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancer

21. Kidney Biopsy in Patients with Cancer along the Last Decade: A Multicenter Study

22. FC 116: SGLT2 Inhibitors in Kidney Transplantation: A Multicenter Study

23. MO1018: Nephrotic Syndrome as a Paraneoplastic Entity

24. Focal and segmental glomerulosclerosis associated with COVID-19 infection

26. Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancer

28. Safety of Obtaining an Extra Biobank Kidney Biopsy Core

29. COVID-19 in Patients with Glomerular Disease: Follow-Up Results from the IRoc-GN International Registry

38. MO151CLINICAL COURSE AND OUTCOMES OF COVID-19 PATIENTS WITH BIOPSY-PROVEN GLOMERULAR AND TUBULAR KIDNEY DISEASE. LOW HEMOGLOBIN LEVELS AS A RISK FACTOR FOR MORTALITY

39. MO160COVID-19 INFECTION AND ACUTE TUBULOINTERSTITIAL NEPHRITIS

40. MO288NEPHROTIC SYNDROME AS A PARANEOPLASTIC ENTITY: ARE WE KEEPING IT IN MIND?

41. MO141ACUTE KIDNEY INJURY AS A RISK FACTOR FOR MORTALITY IN ONCOLOGICAL PATIENTS RECEIVING CHECK-POINT INHIBITORS

42. Antimyeloperoxidase and proteinase 3 antibodies for nephritis flare prediction in ANCA-associated-vasculitis

43. Acute kidney injury as a risk factor for mortality in oncological patients receiving checkpoint inhibitors.

45. Acute kidney injury as a risk factor for mortality in oncological patients receiving checkpoint inhibitors

46. Anti-myeloperoxidase and proteinase 3 antibodies for nephritis flare prediction in anti-neutrophil cytoplasmic antibody–associated vasculitis

47. Anti-myeloperoxidase and proteinase 3 antibodies for nephritis flare prediction in anti-neutrophil cytoplasmic antibody–associated vasculitis.

49. GLP-1 Receptor agonists and diabetic kidney disease: A call of attention to nephrologists

50. Challenges in primary focal segmental glomerulosclerosis diagnosis : from the diagnostic algorithm to novel biomarkers

Catalog

Books, media, physical & digital resources